Mouse Anti-HIV-1 Tat (AA 47-58) Recombinant Antibody (CBMW-H0397) (CBMAB-V208-0448-FY)

Basic Information
Formulations & Storage [For reference only, actual COA shall prevail!]
Target
Extracellular circulating Tat can be endocytosed by surrounding uninfected cells via the binding to several surface receptors such as CD26, CXCR4, heparan sulfate proteoglycans (HSPG) or LDLR. Neurons are rarely infected, but they internalize Tat via their LDLR. Through its interaction with nuclear HATs, Tat is potentially able to control the acetylation-dependent cellular gene expression. Modulates the expression of many cellular genes involved in cell survival, proliferation or in coding for cytokines or cytokine receptors. Tat plays a role in T-cell and neurons apoptosis. Tat induced neurotoxicity and apoptosis probably contribute to neuroAIDS. Circulating Tat also acts as a chemokine-like and/or growth factor-like molecule that binds to specific receptors on the surface of the cells, affecting many cellular pathways. In the vascular system, Tat binds to ITGAV/ITGB3 and ITGA5/ITGB1 integrins dimers at the surface of endothelial cells and competes with bFGF for heparin-binding sites, leading to an excess of soluble bFGF.
Modulation by virus of host chromatin organization Source: UniProtKB-UniRule
Modulation by virus of host PP1 activity Source: UniProtKB-UniRule
Modulation of transcription in other organism involved in symbiotic interaction Source: CACAO
Negative regulation of cellular respiration Source: CACAO
Negative regulation of peptidyl-threonine phosphorylation Source: UniProtKB-UniRule
Positive regulation of NF-kappaB transcription factor activity Source: CACAO
Positive regulation of protein localization to nucleus Source: CACAO
Positive regulation of transcription elongation from RNA polymerase II promoter Source: UniProtKB-UniRule
Positive regulation of viral transcription Source: UniProtKB-UniRule
Suppression by virus of host type I interferon-mediated signaling pathway Source: UniProtKB-UniRule
Transcription, DNA-templated Source: UniProtKB-UniRule
Acetylation by EP300, CREBBP, GCN5L2/GCN5 and PCAF regulates the transactivation activity of Tat. EP300-mediated acetylation of Lys-50 promotes dissociation of Tat from the TAR RNA through the competitive binding to PCAF's bromodomain. In addition, the non-acetylated Tat's N-terminus can also interact with PCAF. PCAF-mediated acetylation of Lys-28 enhances Tat's binding to CCNT1. Lys-50 is deacetylated by SIRT1.
Polyubiquitination by host MDM2 does not target Tat to degradation, but activates its transactivation function and fosters interaction with CCNT1 and TAR RNA.
Phosphorylated by EIF2AK2 on serine and threonine residues adjacent to the basic region important for TAR RNA binding and function. Phosphorylation of Tat by EIF2AK2 is dependent on the prior activation of EIF2AK2 by dsRNA.
Submit a review and get a Coupon or an Amazon gift card. 20% off Coupon

Submit a review

Please try the standard protocols which include: protocols, troubleshooting and guide.
Enzyme-linked Immunosorbent Assay (ELISA)
Flow Cytometry
Immunofluorescence (IF)
Immunohistochemistry (IHC)
Immunoprecipitation (IP)
Western Blot (WB)
Enzyme-Linked Immunospot (ELISpot)
Proteogenomics
Other Protocols
Related Products
Mouse Anti-HIV-1 Tat (AA 59-67) Recombinant Antibody (CBMW-H0405) (CAT#: CBMAB-V208-0456-FY)
Mouse Anti-HIV-1 Tat Recombinant Antibody (CBMW-H0805) (CAT#: CBMAB-V208-0921-FY)
Mouse Anti-HIV-1 Tat Recombinant Antibody (CBMW-H0134) (CAT#: CBMAB-V208-0154-FY)
Mouse Anti-HIV-1 Tat (AA 2-9) Recombinant Antibody (CBMW-H0376) (CAT#: CBMAB-V208-0426-FY)
Mouse Anti-HIV-1 Tat (AA 71-81) Recombinant Antibody (CBMW-H0415) (CAT#: CBMAB-V208-0466-FY)
Mouse Anti-HIV-1 Tat Recombinant Antibody (CBMW-H0804) (CAT#: CBMAB-V208-0920-FY)
Custom Antibody Labeling
We also offer labeled antibodies developed using our catalog antibody products and nonfluorescent conjugates (HRP, AP, Biotin, etc.) or fluorescent conjugates (Alexa Fluor, FITC, TRITC, Rhodamine, Texas Red, R-PE, APC, Qdot Probes, Pacific Dyes, etc.).
Online InquiryContact us
